Journal
Molecular Therapy: Methods & Clinical Development
Publication Date
3-14-2024
Volume
32
Issue
1
First Page
101205
Document Type
Open Access Publication
DOI
10.1016/j.omtm.2024.101205
Rights and Permissions
Doshi BS, Samelson-Jones BJ, Nichols TC, Merricks EP, Siner JL, French RA, Lee BJ, Arruda VR, Callan MB. AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life. Mol Ther Methods Clin Dev. 2024 Feb 2;32(1):101205. doi: 10.1016/j.omtm.2024.101205. Copyright 2024 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Doshi, Bhavya S; Samelson-Jones, Benjamin J; Nichols, Timothy C; Merricks, Elizabeth P; Siner, Joshua L; French, Robert A; Lee, Ben J; Arruda, Valder R; and Callan, Mary Beth, "AAV gene therapy in companion dogs with severe hemophilia: Real-world long-term data on immunogenicity, efficacy, and quality of life." Molecular Therapy: Methods & Clinical Development. 32, 1. 101205 (2024).
https://digitalcommons.wustl.edu/oa_4/5778
Additional Links
Supplemental material is available for this article at publisher site.
